$INMD

InMode Shares Jump After Steel Partners Tables Higher Takeover Proposal (INMD)

InMode Ltd (INMD) shares rose about 4% premarket after Steel Partners Holdings proposed to buy the medical aesthetics company for $16.75 per share in cash, a 20% premium to $13.95 and above a prior $16.20 bid by CEO Moshe Mizrahy. Steel Partners urged an independent committee, questioned governance and possible MNPI around share purchases, and cited 2026 adj. EBITDA of $65M vs guidance $73M-$78M.

Original reporting
Published Jul 9, 2026, 2:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 9, 2026, 2:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
InMode Shares Jump After Steel Partners Tables Higher Takeover Proposal (INMD) — source image
Decision brief

The 30-second read

$INMDBullishMed
01

Why it matters

The disclosed offer price ($16.75) and premium framing, plus allegations about timing of share purchases and EBITDA valuation versus guidance, can shift deal probability and expected offer size.

02

Market read

A higher competing bid and a board-response deadline create a near-term catalyst window for INMD.

03

What to watch

Steel Partners is a major shareholder, but the article does not confirm financing certainty, regulatory path, or whether the board will accept the structure or remove the CEO.

Relevance 9/10Novelty 7/10Timing: pre-market today, ahead of InMode board response deadline (5:00 p.m. ET on 13 July)

Background

Steel Partners, a major InMode shareholder, submitted a competing acquisition proposal and urged governance changes via a letter to the board.

Company-level read

Ticker impact

$INMDBullishMedium confidence
Context

InMode shares rose pre-market after Steel Partners proposed a $16.75-per-share cash takeover, citing a 20% premium.

Expected impact

Near-term upside bias with elevated volatility as the board responds and investors reprice deal odds.

Evidence & confidence

The article discloses a fresh bid price ($16.75), a competing prior bid ($16.20), and specific board demands (independent committee, CEO removal request) that can drive immediate repricing and process-driven headlines.

Market effects

Could increase deal activity expectations in medical aesthetics by highlighting shareholder-led M&A pressure and governance scrutiny.

Limited, as the catalyst is company-specific and US-listed.

Low, unless the buyer consortium structure or manufacturing/distribution partners trigger broader cross-border scrutiny.

Counterpoint

The bid may not clear due to governance concerns and valuation disputes, so the stock could retrace if the board rejects or negotiates down.

Key entities

  • InMode Ltd

    NASDAQ-listed medical aesthetics company receiving a competing takeover proposal.

  • Steel Partners Holdings L.P.

    Major InMode shareholder proposing to acquire the company for $16.75 per share in cash.

  • Moshe Mizrahy

    InMode CEO whose actions and governance are challenged in the shareholder letter.

Related articles

$INMDMedAI 8/10

InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025

InMode Ltd. (Nasdaq: INMD) reported Q2 2026 GAAP revenues of $95.6M, unchanged vs Q2 2025. Consumables and service rose 13% to $22.3M. GAAP net income was $17.1M ($0.29/diluted share). Cash and equivalents plus marketable securities totaled $501.1M at June 30, 2026. FY2026 outlook: revenues $365M-$375M and non-GAAP EPS $1.29-$1.34.

$INMDMed

InMode Ltd. (INMD): Financial results for Q2 2026

InMode Ltd. (INMD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 YOKNEAM, Israel, August 5, 2026 - InMode Ltd. (Nasdaq: INMD) (“InMode”) , a leading global provider of innovative medical techno

$INMDMed

InMode Confirms Receipt of Unsolicited Proposal

InMode Ltd. (NASDAQ: INMD) said its board received an unsolicited acquisition proposal from Steel Partners Holdings L.P., dated July 9, 2026. A special committee of independent directors will review the proposal with legal and financial advisors. The committee said it will not comment further for now.

$INMDHighAI 9/10

InMode stock surges on Steel Partners’ $16.75 buyout offer By Investing.com

InMode Ltd (NASDAQ:INMD) shares rose about 4% premarket after Steel Partners Holdings offered to buy the company for $16.75 per share in cash. Steel Partners, a major shareholder, cited a 20% premium to $13.95 and said it would allow rollover of up to 40% of equity into Steel-owned InMode. It urged an independent committee, challenged CEO Moshe Mizrahy, and referenced 2026 adjusted EBITDA of $65 million versus guidance of $73 million to $78 million.

$SLEMedAI 8/10

Super League buys its first Bitcoin for $83,041 ahead of Metaplanet deal

Super League Enterprise (NASDAQ: SLE) bought its first Bitcoin for $83,041.40 on October 10, 2026, ahead of a shareholder vote on a deal with Metaplanet Inc. (TSE: 3350) to acquire 2,100 Bitcoin and $2.5 million in cash. The deal, valued at $179 million, would give Metaplanet 95.7% of Super League's stock. The vote is scheduled for October 16, 2026, with closing expected in Q4 2026.